Lowering the Bar

My son had a wonderful fourth grade teacher.  She was new to the profession and had a progressive and positive attitude towards teaching.  Unfortunately for her class, there was a student that probably took up forty percent of her time.  He was older, larger and tended to bully the other students.  The quality of education in this classroom dropped, not because the teacher was substandard, it was the educational policies that dictated that limited time and resources should be directed at negatives instead of positives.  The bar was lowered many years ago and our educational system continues to suffer today.

This same failed policy philosophy is playing out for supporters of medical marijuana.  The federal government is determined to focus on the bullies (drug dealers), while totally ignoring the needs of the other students (patients that have demonstrated a legitimate medical need for cannabis).  Although it is true that there are greedy opportunists that will disrespect state medical marijuana laws in order to turn a profit, there is a fairness factor.  Why should those suffering be denied access to a product that would ease their suffering?  That is an inhumane, unethical, not to mention un-American act.

A growing substance abuse problem is pharmaceuticals.  People are using legal drugs for a recreational high, instead of the medicinal intent.  But does this mean we should outlaw all pain medication?  Of course not, that is an irrational, emotional and unproductive response.  People struggling with legitimate medical issues should not be denied access to products to ease their pain.

The reason why medical cannabis should be added to list of possible treatment options is because it isn’t possible to become physically addicted to cannabis.  Comparable pain relieving pharmaceuticals carry the threat of physical addiction and numerous side effects.  It isn’t good policy to deny access to a drug that is not physically addictive.  Addiction is hell and the government should not push legal addictive drugs at medical patients, while denying them access to milder non-addictive products.

© Copyright 2011. Fawkes-Lee & Ryan


This entry was posted in Medical Cannabis and tagged , , . Bookmark the permalink.

One Response to Lowering the Bar

  1. Ryan Meyer says:

    Submitted on 2011/07/10 at 3:27 pm
    On June 21st, the DEA denied rescheduling marijuana because, in part, “there are presently no US Food and Drug Administration approved marijuana products.”

    Talk about a circular argument…

Leave a Reply

Your email address will not be published. Required fields are marked *

* Copy This Password *

* Type Or Paste Password Here *